ConductScience.org, home

Paper4348463

1 -Hydroxy derivative of vitamin D 3 : a highly potent analog of 1 ,25-dihydroxyvitamin D 3 .

Holick MF and 3 others. Science, 1973. Cited by 183 papers, by iCite.

Cite this record

ConductScience Library. 1 -Hydroxy derivative of vitamin D 3 : a highly potent analog of 1 ,25-dihydroxyvitamin D 3 . Papers, record 4348463. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4348463

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
1 -Hydroxy derivative of vitamin D 3 : a highly potent analog of 1 ,25-dihydroxyvitamin D 3 .
PubMed
Journal
Science
PubMed
Year
1973
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
183
iCite
Relative citation ratio, by iCite
6.44
iCite
Revised in PubMed
2019-06-18
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Holick MFM F
2Semmler EJE J
3Schnoes HKH K
4DeLuca HFH F

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CholecalciferolMajor topic
Animals
Biological Assay
Biological Transport
Bone and Bones
Calcium
Intestinal Mucosa
Male
Rats
Time Factors

Source PubMed

Download CSV of topics

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 183 citations.

PMIDTitleJournalYearIn PapersSource
36771300The One-Hundred-Year Anniversary of the Discovery of the Sunshine Vitamin D3: Historical, Personal Experience and Evidence-Based Perspectives.Nutrients2023https://conductscience.org/library/papers/36771300PubMed
35245207100 YEARS OF VITAMIN D: Historical aspects of vitamin D.Endocr Connect2022https://conductscience.org/library/papers/35245207PubMed
34940947Vitamin D: Dosing, levels, form, and route of administration: Does one approach fit all?Rev Endocr Metab Disord2021https://conductscience.org/library/papers/34940947PubMed
25931412
The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).
Endocrine2015https://conductscience.org/library/papers/25931412PubMed
24809324Alfacalcidol enhances collagen quality in ovariectomized rat bones.J Orthop Res2014https://conductscience.org/library/papers/24809324PubMed
19778452Treatment of secondary hyperparathyroidism in haemodialysis patients: a randomised clinical trial comparing paricalcitol and alfacalcidol.BMC Nephrol2009https://conductscience.org/library/papers/19778452PubMed
7319902Osteoclast formation in response to intraperitoneal injection of 1 alpha-hydroxycholecalciferol in mice.J Anat1981https://conductscience.org/library/papers/7319902PubMed
6775785Effects of 1 alpha-hydroxy vitamin D3 on the rachitic chick intestine: a comparison to the effects of 1,25-dihydroxyvitamin D3.Calcif Tissue Int1980https://conductscience.org/library/papers/6775785PubMed
4441974The effects of vitamin D analogues on bone resorption.Calcif Tissue Res1974https://conductscience.org/library/papers/4441974PubMed
4372612Vitamin D: concerning the relationship between molecular topology and biological function.Proc Natl Acad Sci U S A1974https://conductscience.org/library/papers/4372612PubMed
4365934Metabolism and action of the hormone vitamin D. Its relation to diseases of calcium homeostasis.West J Med1974https://conductscience.org/library/papers/4365934PubMed
4365368Biological activity of 1alpha-hydroxycholecalciferol, a synthetic analog of the hormonal form of vitamin D3.Proc Natl Acad Sci U S A1973https://conductscience.org/library/papers/4365368PubMed
3093033Treatment of psoriasis vulgaris by oral administration of 1 alpha-hydroxyvitamin D3--open-design study.Calcif Tissue Int1986https://conductscience.org/library/papers/3093033PubMed
1120218I alpha-hydroxycholecalciferol: a treatment of renal bone disease.Br Med J1975https://conductscience.org/library/papers/1120218PubMed
1054498Demonstration of the rapid action of pure crystalline 1 alpha-hydroxy vitamin D3 and 1 alpha,25-dihydroxy vitamin D3 on intestinal calcium uptake.Proc Natl Acad Sci U S A1975https://conductscience.org/library/papers/1054498PubMed
953800The effects of hydroxylated derivatives of vitamin D3 and of extracts of solanum malacoxylon on the absorption of calcium, phosphate and water from the jejunum of pigs.Calcif Tissue Res1976https://conductscience.org/library/papers/953800PubMed
953798The metabolism and function of 1alpha-hydroxyvitamin D3.Calcif Tissue Res1976https://conductscience.org/library/papers/953798PubMed
947957Jejunal and ileal absorption in patients with chronic renal disease. Effect of 1alpha-hydroxycholecalciferol.J Clin Invest1976https://conductscience.org/library/papers/947957PubMed
932193Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.J Clin Invest1976https://conductscience.org/library/papers/932193PubMed
912555The effects of 1alpha-OH cholecalciferol on calcium, magnesium and phosphorus metabolism in dairy heifers, and its potential value for the prevention of milk fever.Calcif Tissue Res1977https://conductscience.org/library/papers/912555PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4348463

GET https://conductscience.org/api/papers/v1/4348463/cited_by?page=2